Table 1.
Testing Need | Patient Population | Test Biomarker | Test Format |
---|---|---|---|
Diagnosis | |||
General Screening | People of unknown status | Antibodies | Lateral Flow Assay |
Acute Infection | Exposed infants & High Risk Groups | Viral Marker: RNA, proviral DNA, p24 | Molecular Test or Lateral Flow Assay, 4th Generation RDT |
Monitoring | |||
Treatment Monitoring | Patients on ART | Viral RNA | Molecular Test |
Drug Resistance | VL>1000cp/ml; Treatment Failure | Viral RNA | Molecular; Sequencing |